
Meet our Trustee: Colin McArthur
Colin McArthur re-joined the board in 2024 after serving as a trustee between January 2008 and September 2019.
Search results
Colin McArthur re-joined the board in 2024 after serving as a trustee between January 2008 and September 2019.
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
Join Research Development Manager, Kate Arkell as she speaks to our latest research grantees about their projects.
Retina UK is delighted that the Scottish Medicines Consortium (SMC) has accepted the gene therapy Luxturna (voretigene neparvovec) for ongoing use by the NHS in Scotland.
New stem cell treatment gains approval to enter US clinical trials
Our monthly e-Newsletter featuring the latest updates from Retina UK.
Our monthly e-Newsletter featuring the latest updates from Retina UK.
Our monthly e-Newsletter featuring the latest updates from Retina UK.